Andy, similiar to me mate......I've averaged down to 12...

Andy, similiar to me mate......I've averaged down to 12 cents.....And believe
it not I am feeling a bit average at the moment.....
Looking for a light at the end of the tunnel, I can't think of much....However...

The fact that the immutep takeover has involved their personal as well as their
product is a positive.......Immuteps hierachy is well credentialled and proven
negotiators.......

For a once private company to interest so many big Pharma leads one
to think that there must be something there......

Big pharma are only chasing one thing......Big Money....

Probably the most important thing to focus on is that the takeover has
given Prima the chance to take to market(if all goes well) their Lag-3
ventures......In this regard we are not starting from scratch and research
is well advanced......Something could happen in the close future, Maybe......

But.....

I must admit it is hard to argue with our fellow investors
when they question the lack of engagement with the market of late.....

All I can say is that Prima must have known for a while that it did not
have the capacity to take CVAC any further without a big capital input.
That's OK and I understand it, when the ANN came out re CVAC, it might
not have been a shock to them but it certainly was a shock to us.....

I don't think you could argue with disgruntled shareholders when they
criticise the lack of promotion of late by the company.....